Oruka Therapeutics
Price & Volume
Stats
See more52W Range | $14.89-$115.52 |
Market Cap | $6.2B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.98 |
News
See moreYahoo Finance • last month
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?
Yahoo Finance • last month
Oruka Q2 Net Loss Expands; Expects Phase 2 EVERLAST-A 28 Week Data Of ORKA-001 At The End Of Q3 2026
Yahoo Finance • last month
Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
About
CEO | Dr. Lawrence Otto Klein Ph.D. |
Address | 855 Oak Grove Avenue, Menlo Park, CA, United States, 94025 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 68 |